SCHEMBL277895

SCHEMBL277895

OP(O)(O)=S.OP(O)(O)=S.OP(O)(O)=S.OP(O)(O)=S

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALPG P10696 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL992305 1.00 ALPG (0.31) ALPG
SCHEMBL28461987 1.00 ALPG (0.31) ALPG
SCHEMBL7821 1.00
SCHEMBL29357 1.00 ALPG (0.31) ALPG
Phosphine SCHEMBL25176319 0.93
SCHEMBL21044700 0.93
SCHEMBL6048215 0.93
SCHEMBL22664583 0.93
SCHEMBL20556065 0.93
SCHEMBL8607977 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115745126-A Heavy metal wastewater treatment method and application 深圳市清源净水器材有限公司 2023-03-07 CN claimed
CN-115181164-A Derivatives of amatoxins and their coupling to cell binding molecules 杭州多禧生物科技有限公司 2022-10-14 CN claimed
CN-112272669-A Cross-linked pyrrolobenzodiazepine dimer (PBD) derivatives and conjugates thereof 杭州多禧生物科技有限公司 2021-01-26 CN claimed
EP-1960454-B1 POLYORGANOSILOXANE COMPOSITION FOR USE IN UNSATURATED ELASTOMER, ARTICLE MADE THEREFROM, AND ASSOCIATED METHOD CONTINENTAL REIFEN DEUTSCHLAND GMBH (DE) 2016-10-12 EP claimed
EP-1960455-B1 POLYORGANOSILOXANE COMPOSITION FOR USE IN UNSATURATED ELASTOMER, ARTICLE MADE THEREFROM, AND ASSOCIATED METHOD CONTINENTAL REIFEN DEUTSCHLAND (DE) 2011-06-08 EP claimed
EP-1831232-A2 CYCLIC DIOL-DERIVED BLOCKED MERCAPTOFUNCTIONAL SILANE COMPOSITIONS General Electric Company (US) 2007-09-12 EP claimed
WO-2006023785-A2 CYCLIC DIOL-DERIVED BLOCKED MERCAPTOFUNCTIONAL SILANE COMPOSITIONS GENERAL ELECTRIC COMPANY (US) 2006-03-02 WO claimed
US-6890980-B2 Synthesis of block polymers obtained by controlled free radical polymerization Chimie, Rhodia 2005-05-10 US claimed
US-20040030041-A1 Synthesis of block polymers obtained by controlled free radical polymerization RHODIA CHIMIE (FR) 2004-02-12 US claimed
EP-1337562-A1 SYNTHESIS OF BLOCK POLYMERS OBTAINED BY CONTROLLED FREE RADICAL POLYMERISATION RHODIA CHIMIE (FR) 2003-08-27 EP claimed
WO-2002096955-A1 RADICAL POLYMERIZATION USING TRANSFER AGENTS CONTAINING PHOSPHORUS AND SULFUR ATOFINA (FR) 2002-12-05 WO claimed
WO-2002036640-A1 SYNTHESIS OF BLOCK POLYMERS OBTAINED BY CONTROLLED FREE RADICAL POLYMERISATION RHODIA CHIMIE (FR) 2002-05-10 WO claimed
EP-0468477-B1 Process for producing dihydric phenols DAINIPPON INK & CHEMICALS (JP) 1995-01-11 EP claimed
US-4886610-A EXTREME PRESSURE LUBRICANTS CIBA-GEIGY CORPORATION (US) 1989-12-12 US claimed
US-4189453-A FROM MERCAPTANS AND PHOSPHORUS TRIHALIDE, CATALYTIC CIBA-GEIGY CORPORATION (US) 1980-02-19 US claimed
US-20260031400-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) 2026-01-29 US disclosed
US-20260031394-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) 2026-01-29 US disclosed
US-4034024-A FROM DIALKYL SULFIDE AND PHOSPHORUS PENTASULFIDE STAUFFER CHEMICAL COMPANY (US) 1977-07-05 US disclosed
US-4002686-A Method of preparing primary aliphatic mercaptans THE LUBRIZOL CORPORATION (US) 1977-01-11 US disclosed
US-4002807-A INCREASED CHARGEDISCHARGE CAPACITY FORD MOTOR COMPANY (US) 1977-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260031394-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME SMC1A, SMC2, SMC4 ALPG 3328/4885
US-20260031400-A1 ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME KCNN1, KCNN2, ILK ALPG 3694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.